Hidehiko Akashi

2PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 28, 2025
Bevacizumab in frontline chemotherapy improved the survival outcome for advanced ovarian clear cell carcinoma: a multicenter retrospective analysis.

Shinichi Tate, Toshiyuki Seki, Kyoko Nishikimi

|Sep 17, 2023
SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma.

Hidehiko Akashi, Nozomi Yachida, Haruka Ueda

Pageof 1

Frequent Collaborators

2 joint publications

Kosuke Yoshihara

1 joint publications

Nozomi Yachida

1 joint publications

Haruka Ueda

1 joint publications

Manako Yamaguchi